Equity

IBB

iShares Nasdaq Biotechnology ETF

Overview

Important Information: Capital at Risk. All financial investments involve an element of risk. Therefore, the value of your investment and the income from it will vary and your initial investment amount cannot be guaranteed.

Show Fewer
Loading

Performance

Performance

  • Returns

  From
31-Mar-2014
To
31-Mar-2015
From
31-Mar-2015
To
31-Mar-2016
From
31-Mar-2016
To
31-Mar-2017
From
31-Mar-2017
To
31-Mar-2018
From
31-Mar-2018
To
31-Mar-2019
Total Return (%) Total return is expressed as the percentage change of an investment over a certain timeframe. It includes the net income earned by the investment in terms of dividends or interest along with any change in the capital value of the investment.

as of 31-Mar-19

45.69 -24.09 12.75 9.41 4.92
Benchmark (%) Index: Nasdaq Biotechnology Index(R)

as of 31-Mar-19

46.03 -23.90 13.04 9.81 5.24
  YTD 1m 3m 6m 1y 3y 5y 10y Incept.
15.45 -0.83 15.45 -8.33 4.92 29.43 43.15 415.82 244.45
Market Price (%) Market price return represents changes to the midpoint price and accounts for distributions from the fund. The midpoint is the average of the bid-ask prices at 4:00 PM ET (when NAV is normally determined for most funds).

as of 31-Mar-19

15.50 -0.80 15.50 -8.28 4.95 29.55 43.19 416.21 244.61
Benchmark (%) Index: Nasdaq Biotechnology Index(R)

as of 31-Mar-19

15.54 -0.81 15.54 -8.18 5.24 30.63 45.16 430.83 265.01
After Tax Pre-Liq. (%) Return after taxes on distributions. Assumes fund shares have not been sold.

as of 31-Mar-19

15.45 -0.83 15.45 -8.33 4.88 29.25 42.85 413.85 242.84
After Tax Post-Liq. (%) Return after taxes on distributions and sale of fund shares.

as of 31-Mar-19

9.15 -0.49 9.15 -4.93 2.94 22.42 32.85 316.45 185.82

The figures shown relate to past performance. Past performance is not a reliable indicator of future results and should not be the sole factor of consideration when selecting a product or strategy.

Share Class and Benchmark performance displayed in USD, hedged fund benchmark performance is displayed in USD.

Performance is shown on a Net Asset Value (NAV) basis, with gross income reinvested where applicable. Performance data is based on the net asset value (NAV) of the ETF which may not be the same as the market price of the ETF. Individual shareholders may realize returns that are different to the NAV performance.

The return of your investment may increase or decrease as a result of currency fluctuations if your investment is made in a currency other than that used in the past performance calculation. Source: Blackrock

Chart

Performance chart data not available for display.
View full chart

Distributions

Record Date Ex-Date Total Distribution
View full table

Premium/Discount

Key Facts

Key Facts

Net Assets as of 17-Apr-19 USD 7,479,792,774
Size of Fund (Millions) USD 7,479.793
Base Currency USD
Inception Date 05-Feb-01
Asset Class Equity
Domicile United States
Benchmark Index Nasdaq Biotechnology Index(R)

Portfolio Characteristics

Portfolio Characteristics

Shares Outstanding as of 17-Apr-19 71,200,000
Benchmark Level as of 17-Apr-19 USD 3,417.66
Net Assets as of 17-Apr-19 USD 7,479,792,774.17
Benchmark Ticker XNBI
Fiscal Year End 31-Mar-18

Registered Countries

Registered Countries

  • Finland

  • Luxembourg

  • Netherlands

  • Sweden

  • United Kingdom

  • United States

Holdings

Holdings

as of 17-Apr-19
Ticker ISIN Name Name of Issuer Sector Country Asset Class Nominal Market Value Weight (%) Price Exchange Market Currency Notional Value
Issuer Ticker Name Name of the underlying security Asset Class Weight (%) Price Nominal Market Value Notional Value Sector ISIN Exchange Country Market Currency
Detailed Holdings and Analytics contains detailed portfolio holdings information and select analytics.

Exposure Breakdowns

Exposure Breakdowns

as of 17-Apr-19

% of Market Value

Type Fund
Geographic exposure relates principally to the domicile of the issuers of the securities held in the product, added together and then expressed as a percentage of the product’s total holdings. However, in some instances it can reflect the country where the issuer of the securities carries out much of their business. Bonds are included in US bond indices when the securities are denominated in U.S. dollars regardless of the domicile of the issuer. 
as of 17-Apr-19

% of Market Value

Type Fund
Allocations are subject to change.

Listings

Exchange Ticker Currency Listing Date SEDOL Bloomberg Ticker RIC Bloomberg INAV Reuters INAV ISIN WKN Valor Common Code (EOC) ISIN of INAV
NASDAQ IBB USD 05-Feb-01 - IBB IBB.OQ - IBBiv.OQ US4642875565 - 1194267 - -
Bolsa Mexicana De Valores IBB MXN 30-Jun-09 - - - - - - - - - -
Santiago Stock Exchange IBB CLP 23-Oct-17 - - - - - US4642875565 - - - -

Literature

Literature